The global branded generics market is projected to increase from USD 414.5 billion in 2026 to USD 928.6 billion by 2036, expanding at a compound annual growth rate (CAGR) of 8.4%, according to Future Market Insights (FMI). The market is benefiting from sustained demand for affordable prescription medicines, particularly in chronic disease management, alongside physician familiarity with...